Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Ulm
University of Chicago
Sanofi
University of Washington
Mayo Clinic
University of Michigan Rogel Cancer Center
OHSU Knight Cancer Institute
Alpine Immune Sciences, Inc.
Stingthera, Inc.
University of Washington
Seagen Inc.
Repertoire Immune Medicines
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Rhizen Pharmaceuticals SA